Indefinite Delivery Contract SPE2DR25D1056

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD)...
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and U.S. Naval Fleet. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is an Indefinite...
The federal contract IDV award from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The $999,999,999 single-award Indefinite Delivery Contract (IDC) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical and medical products to support military healthcare programs globally. The contract aims to establish...
The federal contract IDV award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. This unrestricted, single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999 will run through December 2036. The contract's purpose is to provide worldwide pharmaceutical support, including brand-name,...
The federal contract IDV award was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award Indefinite Delivery Contract (IDC), valued at $4,999,999.00, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V to provide worldwide pharmaceutical support, including brand-name, generic, and specialty drugs, vaccines, syringes, and other...
The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDC, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp for a base period of 30 months and three 30-month option periods, with a total estimated value of $30.3 billion. The contract aims to establish Prime Vendor Contracts for the PPV-G program, which provides worldwide...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999.00, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet, through the Pharmaceutical Prime Vendor Global Program...
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract established by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, through an unrestricted competitive acquisition. The...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The contract has a 30-month base period and three 30-month option periods, with a total estimated value of $30.3 billion. The purpose of this contract is to provide worldwide...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The purpose of this contract is to establish Prime Vendor Contracts for the Pharmaceutical...

The federal contract IDV award from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. This single-award, unrestricted Indefinite Delivery Contract (IDC) has a 30-month base period and three 30-month option periods, with a total estimated value of $30.3 billion.

The purpose of this contract is to establish prime vendor agreements for providing worldwide pharmaceutical support, including brand-name, generic, and specialty drugs, as well as related medical supplies, to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the U.S. Coast Guard, and other designated government agencies and healthcare providers. The contract will cover a broad range of pharmaceutical products across multiple therapeutic areas to support normal operations, contingencies, and readiness requirements at both CONUS and OCONUS locations. The award will be made based on the lowest overall distribution fees proposed, with the intention of having at least three different regional prime vendors to increase supply chain resiliency.

Generated 6/6/25, 9:57 AM